Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1036 AL 1050

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein

Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc'h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group.

J Alzheimers Dis. 2016;51(3):905-13. doi: 10.3233/JAD-151111.

The clinical picture of Alzheimer's disease in the decade before diagnosis: clinical and biomarker trajectories

Ritchie K, Carrière I, Berr C, Amieva H, Dartigues JF, Ancelin ML, Ritchie CW.

J Clin Psychiatry. 2016 Mar;77(3):e305-11. doi: 10.4088/JCP.15m09989.

The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease

Hays CC, Zlatar ZZ, Wierenga CE.

Cell Mol Neurobiol. 2016 Mar;36(2):167-79. doi: 10.1007/s10571-015-0261-z. Epub 2016 Feb 22.

Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis

Ma J, Zhang W, Wang HF, Wang ZX, Jiang T, Tan MS, Yu JT, Tan L.

Curr Alzheimer Res. 2016;13(3):223-33. doi: 10.2174/156720501303160217111434.

Biomarkers and Cellular Signal Detection for Alzheimer's Disease, Stroke, and Immune System Mediated Disorders

Maiese K.

Curr Neurovasc Res. 2016;13(2):93-5. doi: 10.2174/1567202613999160226165448.

Alzheimer's disease

Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM.

Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24.

What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?

Andriuta D, Moullart V, Schraen S, Devendeville A, Meyer ME, Godefroy O; Alzheimer’s Disease Neuroimaging.

J Alzheimers Dis. 2016;51(3):793-800. doi: 10.3233/JAD-150829.

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease

Delnomdedieu M, Duvvuri S, Li DJ, Atassi N, Lu M, Brashear HR, Liu E, Ness S, Kupiec JW.

Alzheimers Res Ther. 2016 Mar 1;8(1):12. doi: 10.1186/s13195-016-0177-y.

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

Suárez-Calvet M, Kleinberger G, Araque Caballero MÁ, Brendel M, Rominger A, Alcolea D, Fortea J, Lleó A, Blesa R, Gispert JD, Sánchez-Valle R, Antonell A, Rami L, Molinuevo JL, Brosseron F, Traschütz A, Heneka MT, Struyfs H, Engelborghs S, Sleegers K, Van Broeckhoven C, Zetterberg H, Nellgård B, Blennow K, Crispin A, Ewers M, Haass C.

EMBO Mol Med. 2016 May 2;8(5):466-76. doi: 10.15252/emmm.201506123. Print 2016 May.

Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects

Cantero JL, Iglesias JE, Van Leemput K, Atienza M.

J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1210-5. doi: 10.1093/gerona/glw022. Epub 2016 Mar 4.

ZCWPW1 is associated with late-onset Alzheimer's disease in Han Chinese: a replication study and meta-analyses

Gao Y, Tan MS, Wang HF, Zhang W, Wang ZX, Jiang T, Yu JT, Tan L.

Oncotarget. 2016 Apr 12;7(15):20305-11. doi: 10.18632/oncotarget.7945.

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

Landau SM, Horng A, Fero A, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Apr 12;86(15):1377-1385. doi: 10.1212/WNL.0000000000002576. Epub 2016 Mar 11.

Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease

Wilke C, Gillardon F, Deuschle C, Dubois E, Hobert MA, Müller vom Hagen J, Krüger S, Biskup S, Blauwendraat C, Hruscha M, Kaeser SA, Heutink P, Maetzler W, Synofzik M.

Curr Alzheimer Res. 2016;13(6):654-62. doi: 10.2174/1567205013666160314151247.

Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration

Wang HF, Wan Y, Hao XK, Cao L, Zhu XC, Jiang T, Tan MS, Tan L, Zhang DQ, Tan L, Yu JT; Disease Neuroimaging Initiative Alzheimer’s.

J Alzheimers Dis. 2016 Mar 15;52(1):179-90. doi: 10.3233/JAD-150972.

[Alzheimer's disease and Helicobacter pylori infection: a possible link?]

Roubaud Baudron C, Varon C, Mégraud F, Salles N.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Mar;14(1):86-94. doi: 10.1684/pnv.2016.0584.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias